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Abstract: A i m: The main goal of this study was assessment of vascular structure of uterine leiomy-
omata localized between outer myometrium and endometrium.
M a t e r i a l s  a n d  M e t h o d s: The study was carried out on thirty two human uteri collected upon 
autopsy. Vessels were injected with synthetic resin, next corroded and coated with gold, finally ob-
served using scanning electron microscope. Next ten uteri were injected with acrylic emulsion and 
studies using immunohistochemical staining for von Willebrandt’s factor.
R e s u l t s: Vascular structure of outer myometrial leiomyomata was quite similar to those observed in 
the middle of muscular layer of uterus, characterized by relatively dense ‘vascular capsule’, consisted 
of flattened vein, arterioles and capillaries. 
C o n c l u s i o n s: Structure of outer myometrial uterine leiomyomata was similar to those observed 
during growth within myometrium.
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INTRODUCTION
There is a whole list of different factors which may have an influence on uterine 
leiomyomata risk:
• age at menarche and menopausal status
• reproductive factors








• breast disease [1–5]
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Uterine fibroids being the most common benign female tumors (of age 30–55) 
of the internal genital organs, develop within few locations which are: subse-
rous, intramural, submucous, intracervical and finally intralaminar, when their 
growth proceeds towards the space between the layers of the broad ligament. 
These neoplasms are the first indication for surgery among females in the world, 
maybe apart from the cesarean section [6–10]. However epidemiological studies 
are rather scanty [11]. The structure of the intramural uterine leiomyomata has 
been presented in numerous injection studies [12–21] but so far the vascular 
structure of the leiomyomata growing within the borderline between the serosa 
and myometrium has not been a subject of an analysis. 
Much of the uterine fibroids are asymptomatic, and their detection is a result 
of coincidental discovery (i.e. gynecological examination, usg, tec.). Other symp-
toms include: irregularities in uterine bleeding (i.e. menorrhagia), pelvic pain, 
dysmenorrheal, pressure symptoms, infertility and many others [3, 22].
MATERIAL AND METHODS
The material for this study consisted of 42 uteri obtained during the necropsies 
of the females aged between 34–48. The angioarchitecture of the tumours was 
studied using microcorrosion technique, scanning electron microscopy (SEM) [23] 
and immunohistochemistry, reaction for von Willebrandt’s factor. 
Thirty two uteri were obtained upon autopsy of women aged 25–56 years, 
deceased due to causes not related to disorders of the reproductive system. The 
material was collected 6–24 h after death. Each uterus together with ovaries 
and cervical portion of the vagina was removed in such a way that relatively 
long fragments of uterine and ovarian vessels (arteries and veins) were retained.
Immediately after removal, twenty-two uteri were perfused via the afferent arter-
ies with prewarmed (37oC), heparinized saline (12.5 IU/ml heparin; Polfa, Poland, 
containing 3% dextrane (70 kDa) and 0.025% lidocaine (Lignocaine; Polfa, Poland), 
until the fluid outflowing via the veins was completely transparent (~5 min). Next 
perfusion was continued using a solution of 0.66% paraformaldehyde/0.08% glu-
taraldehyde (Sigma, Germany) in 0.1 mol/l cacodylate buffer, pH 7.4 supplemented 
with 0.2% lidocaine. Finally, the vascular system was injected with 60–80 ml of 
Mercox CL-2R resin (Vilene Comp. Ltd. Japan) containing 0.0625 mg/ml methyl 
acrylate polymerization initiator (Vilene Comp. Ltd., Japan) and the uteri were 
left in a warm water bath (56 oC) for several hours to allow polymerization and 
tempering of the resin.
When the polymerization was completed, the uterine tissues were macerated 
for 5–6 days by repeated baths in 10% potassium hydroxide at 37oC followed by 
washing with warm (50–55oC) running tap water. The obtained vascular casts 
were washed for the next 4–5 days in multiple changes of distilled water under 
mild vacuum conditions, cleaned in 5% trichloroacetic acid for 1–2 days, washed 
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again in distilled water for 2–3 days and freeze-dried in a lyophilizer (Liovag G2; 
Aqua Fina, Germany).
The freeze-dried casts were examined macroscopically, gently dissected [24] to 
expose the vasculature of myomata and stored in an exiccator containing phos-
phorus pentoxide until the microscopic examination. They were then mounted 
onto copper plates using colloidal silver and ‘conductive bridges’ and coated with 
gold. The casts were examined using a JEOL SEM 35-CF scanning electron mi-
croscope at 20–25 kV (Jeol, France).
The vascular beds of next ten uteri were perfused with saline and next in-
jected with the solution of acrylic emulsion (Liquitex R, Binney and Smith, USA) 
[25]. The emulsion was successfully used in some previous studies [26, 27]. The 
specimens were collected mainly from large fibroids >3 cm in diameter. All tissue 
specimens were fixed in 10% formalin and embedded in paraffin wax. Tissue 
blocks were sectioned (4 μm) and section mounted on aminopropyltriethoxysilane 
(APES)-coated slides. The endothelial cell marker was factor VIII-related anti-
gen (FVIII). Next tissue blocks were deparaffinised, hydrogen peroxidase (3%) in 
methanol was applied to tissue sections as an endogenous peroxidase block for 
10 min. Protein blocking steps included the application of 10% normal rabbit 
serum prior to the application of the primary antibody (anti Human von Wille-
brandt factor, Dako, USA) in 20% fetal calf serum. After incubation with primary 
antibody, a biotynyled secondary antibody was applied followed by horseradish 
peroxidase-streptavidin conjugate, and visualization with the chromogen 3-amino 
9-ethylchlorcarbazole (AEC, Zymed, USA) which identifies tissue antigens with 
a red-brown stain. Serial sections were immunostained using the endothelial 
cell marker. Negative controls used substitution of the primary antibody with 
the non-immune serum for the polyclonal factor VIII antibody. The study was 
approved by Ethical Committee of Jagiellonian University (KBET/121/8/2007).
RESULTS AND DISCUSSION
Sampson [17, 18] was probably the first who proposed the role of vascular dis-
orders in the development of presented above symptoms associated with uterine 
fibroids. Blood supply of uterine leiomyomata was studied by Holmgren, Faulkner, 
Farrer-Brown et al., Walocha et al. [12–16, 19–21].
Uterine leiomyomata or fibroids are the most common solid, benign, smooth 
muscle cell tumours in women, affecting up to 70% over 30 years of age. They 
represent an important and significant public health problem because of asso-
ciated symptoms (pelvic pain and pressure, uterine bleeding) and side-effects 
(infertility, loss of pregnancy). It is proved that 25% of women in the third to 
fourth decades of life seek care for leiomyoma-related symptoms. However the 
cause of leiomyomata still remains obscure. It is known that there are a number 
of risk and protective factors for and against fibroid growth related to oestradiol 
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and that there are increased numbers of sex steroid receptors in fibroids com-
pared with myometrium. Human uterine leiomyomata express higher levels of 
peroxisome proliferator-activated receptor , retinoid X receptor , and all-trans 
retinoic acid than myometrium [28]. Other factors that may be associated with 
fibroids etiology include peptide growth factors such as the insulin-like growth 
factor (IGF) family and epidermal growth factor (EGF), transforming growth factor 
beta 3 (TGF-3) as well as possible chromosomal and subsequent gene changes 
within these tumours [29-37]. The corrosion casting technique combined with 
scanning electron microscopy (SEM) is the best currently available method for 
morphological examination of both normal and pathological vascular networks 
[20, 38, 39]. SEM offers high resolution and quasi-three-dimensional image [23]. 
FVIII forms part of the von Willebrand factor complex, plays a part in the co-
agulation cascade and its expression is reduced in smaller, less mature blood 
vessels. The vascular staining for this factor is no different to the other vascular 
markers, i.e. CD 31, CD34. The present study has been undertaken to compare 
the results of studies of vascular network of human uterine fibroids located within 
outer myometrial layer using classical injection, using acrylic emulsion, SEM and 
immunohistochemistry.
The characteristic feature of larger leiomyomata was so called “vascular cap-
sule” [40–46] (Fig. 1). In most of specimens we could observe an avascular fissure 
(Fig. 2) located between leiomyoma and myometrium. Veins of the “capsule” were 
present in the form of irregular flattenings. We observed also the presence of intra-
Fig. 1. Corrosion cast. SEM. Dense “vascular capsule of middle-sized leiomoma (~11–12 mm)  
growing at the border region between subserous and intramural region. Bar = 1000 μm.
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Fig. 2. Corrosion cast. SEM. Uterine corpus — coronal section. Avascular gap (arrows)  
located between the leiomyoma (downwards) and mometrium (upwards). Bar = 1000 μm.
Fig. 3. Light microscope sspecimen. Outer intramural leiomyoma. Arteries injected with acrylic 
emulsion Liquitex R (Binney and Smith, USA). Immunohistochemical staining for von Willebrand 
factor marks not injected small vessels (arrowheads). Injected arteries (*). Bar = 100 μm.
parenchymal septa which commonly gave off the branches. Immunohistochemical 
staining proved the presence of small not injected vessels which penetrated the 
substance of tumour (Fig. 3).
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The vascular structure of outer myometrial tumours was comparable to those 
seen in the uterine cervix or intramural of the very early stage of the develop-
ment. The vessels were mostly arranged in the periphery of the tumour what was 
observable in SEM. The vascular capsule was loose and less dense than that 
seen in the typical intramural tumours, so they presented the exophytic model 
of tumour growth.
Immunostaining proved the fact that single vessels penetrated the substance 
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